Molecular advances in biomedical science require high-quality biospecimens (tissue, body fluid, or other material) which provide macromolecules (DNA/RNA, proteins, enzymes, etc.) that are used for diagnostic, therapeutic, and epidemiologic purposes, allowing researchers to better link molecular and clinical information. Today, biospecimen collections are used by multiple groups for varying aims from basic research through clinical trials. Investigators realize that the proper collection, processing, storage, and tracking of biospecimens are critical components of biomarker-related studies.

Thus, by necessity, biobanking is both a science and a business; therefore, BioBanking: Maximizing Your Investment focuses on both angles.